CIM
Contravisory Investment Management Portfolio holdings
AUM
$508M
1-Year Return
23.42%
This Quarter Return
+4.84%
1 Year Return
+23.42%
3 Year Return
+97.74%
5 Year Return
+193.46%
10 Year Return
+427.78%
AUM
$273M
AUM Growth
+$10M
(+3.8%)
Cap. Flow
-$273K
Cap. Flow
% of AUM
-0.1%
Top 10 Holdings %
Top 10 Hldgs %
26.75%
Holding
311
New
35
Increased
121
Reduced
61
Closed
38
Top Buys
| 1 |
Lockheed Martin
LMT
|
$5.14M |
| 2 |
General Dynamics
GD
|
$5.02M |
| 3 |
McKesson
MCK
|
$4.91M |
| 4 |
Qorvo
QRVO
|
$555K |
| 5 |
Dover
DOV
|
$418K |
Top Sells
| 1 |
Progressive
PGR
|
$7.03M |
| 2 |
Cheniere Energy
LNG
|
$5.44M |
| 3 |
Darden Restaurants
DRI
|
$3.58M |
| 4 |
Tractor Supply
TSCO
|
$491K |
| 5 |
Cooper Companies
COO
|
$450K |
Sector Composition
| 1 | Technology | 21.74% |
| 2 | Industrials | 14.76% |
| 3 | Consumer Staples | 13.24% |
| 4 | Healthcare | 10.62% |
| 5 | Real Estate | 8.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Ecolab
ECL
$78B
| $82K | 0.03% |
426
+47
| +12% | +$9.05K |
|
202
Marathon Petroleum
MPC
$54.4B
| $82K | 0.03% |
+1,359
| New | +$82K |
|
203
Boston Scientific
BSX
$159B
| $81K | 0.03% |
1,796
+262
| +17% | +$11.8K |
|
204
Nice
NICE
$8.56B
| $77K | 0.03% |
498
-7
| -1% | -$1.08K |
|
205
Oracle
ORCL
$626B
| $77K | 0.03% |
1,445
+152
| +12% | +$8.1K |
|
|
INFO
206
DELISTED
IHS Markit Ltd. Common Shares
INFO
| $77K | 0.03% |
1,022
-14
| -1% | -$1.06K |
|
207
Amazon
AMZN
$2.51T
| $76K | 0.03% |
820
| – | – |
|
208
Johnson Controls International
JCI
$70.1B
| $75K | 0.03% |
1,843
| – | – |
|
209
NVIDIA
NVDA
$4.18T
| $75K | 0.03% |
+12,720
| New | +$75K |
|
210
Home Depot
HD
$410B
| $74K | 0.03% |
341
-1
| -0.3% | -$217 |
|
211
Union Pacific
UNP
$132B
| $72K | 0.03% |
401
-35
| -8% | -$6.28K |
|
212
Canadian Pacific Kansas City
CP
$70.5B
| $71K | 0.03% |
1,390
-20
| -1% | -$1.02K |
|
213
Norfolk Southern
NSC
$62.8B
| $70K | 0.03% |
360
| – | – |
|
214
Diageo
DEO
$61B
| $68K | 0.02% |
402
+16
| +4% | +$2.71K |
|
215
AstraZeneca
AZN
$254B
| $64K | 0.02% |
1,289
-17
| -1% | -$844 |
|
216
SPDR Gold Trust
GLD
$110B
| $64K | 0.02% |
450
| – | – |
|
217
iShares S&P 500 Value ETF
IVE
$41.2B
| $62K | 0.02% |
473
-240
| -34% | -$31.5K |
|
218
GSK
GSK
$79.8B
| $61K | 0.02% |
1,042
-15
| -1% | -$878 |
|
219
Manulife Financial
MFC
$52.5B
| $61K | 0.02% |
+2,990
| New | +$61K |
|
220
AbbVie
ABBV
$376B
| $58K | 0.02% |
650
| – | – |
|
221
Canadian National Railway
CNI
$60.4B
| $56K | 0.02% |
620
-9
| -1% | -$813 |
|
222
iShares S&P 500 Growth ETF
IVW
$63.7B
| $56K | 0.02% |
1,160
-608
| -34% | -$29.4K |
|
223
Elbit Systems
ESLT
$22.2B
| $55K | 0.02% |
357
-5
| -1% | -$770 |
|
|
CIM
224
Chimera Investment
CIM
$1.19B
| $50K | 0.02% |
811
+376
| +86% | +$23.2K |
|
225
AB InBev
BUD
$116B
| $48K | 0.02% |
582
-7
| -1% | -$577 |
|